Cor Vasa 2009, 51(10):698-707 | DOI: 10.33678/cor.2009.172
Isolated systolic hypertension in the elderly
- Klinika kardiologie, Institut klinické a experimentální medicíny, Praha, Česká republika
The incidence of isolated systolic hypertension starts to increase with age over 50 years. Systolic blood pressure (BP) has a higher prognostic value than diastolic BP in those aged over 50 years. Treatment of isolated systolic hypertension significantly decreases the incidence of stroke, coronary events, and total mortality. Most of the studies demonstrating the above facts were conducted in the early 1990s. In all these studies, the baseline systolic BP was ≥ 160 mmHg. This was because isolated systolic hypertension was defined at that time as a systolic BP ≥ 160 mmHg and diastolic BP < 95 mmHg.
There has been no study to date showing that decreasing systolic BP in the elderly with initial BP of 140-159 mmHg has a beneficial effect on morbidity and mortality and aiming to achieve systolic BP < 140 mmHg. The recommendation of goal levels < 140 mmHg also in the elderly is based primarily on observational studies. Another problem to be still solved is the potential existence of the diastolic BP J-curve in patients with coronary heart disease. Likewise, no randomized trial comparing diastolic BP levels of < 80 mmHg, < 70 mmHg, and < 60 mmHg has been reported.
The guidelines of the European Society of Hypertension and the European Society of Cardiology define goal values for isolated systolic hypertension as < 140/90 mmHg. In patients with diabetes, those with cardiovascular or renal disease (status after myocardial infarction, after stroke, and renal dysfunction), also, in metabolic syndrome patients and patients whose overall cardiovascular risk, using SCORE, is ≥ 5%, the guidelines recommend the decrease of BP to the value < 130/80 mmHg.
We believe that, against the background of contradictory data regarding the J-curve of the relationship of diastolic BP and coronary events, caution is to be exercised in elderly patients with isolated systolic hypertension and coronary heart disease in cases where diastolic BP on therapy declines to < 70 mmHg. In such cases, we will not insist on achieving goal systolic BP. In our opinion, this should apply particularly to elderly patients with coronary heart disease.
Keywords: Systolic hypertension; Treatment of systolic hypertension; Goal BP values on therapy
Published: October 1, 2009 Show citation
References
- Filipovský J. Arteriální hypertenze ve stáří. Cor Vasa 1998;40:291-8.
- Kannel WB, Wolf PA, McGee DL, et al. Systolic blood pressure, arterial rigidity and stroke. The Framingham study. JAMA 1981;245:1225-8.
Go to original source...
- Williams B, Lindholm L, Sever P. Systolic pressure is all that matters. Lancet 2008;372: 2219-21.
Go to original source...
Go to PubMed...
- National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program working group report on hypertension in the elderly. Hypertension 1994;23:275-85.
Go to original source...
Go to PubMed...
- Psaty BM, Furberg CD, Kuller LH, et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality. Arch Intern Med 2001;161:1183-92.
Go to original source...
Go to PubMed...
- Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994;23:395-401.
Go to original source...
Go to PubMed...
- Franklin SS, Jacobs MJ, Wong ND, et al. Predominance of isolated systolic hypertension among moderately aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES III). Hypertension 2001;37:869-74.
Go to original source...
Go to PubMed...
- SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
Go to original source...
- Staessen JA, Fagard R, Thijs L, et al, for the Systolic Hypertension-Europe (Syst-Eur) Trial Investigators. Morbidity and mortality in the placebo-controlled European Trial on Isolated Systolic Hypertension in the Elderly. Lancet 1997;360:757-64.
Go to original source...
Go to PubMed...
- Liu L, Wang JG, Gong I, Liu G, Staessen JA. Comparison of active treatment and placebo in older patients with isolated systolic hypertension. J Hypertens 1998;16:1823-9.
Go to original source...
Go to PubMed...
- Staessen JA, Fagard R, Thijs L, et al, for the Systolic Hypertension in Europe Trial Investigators. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. Arch Intern Med 1998;158:1681-91.
Go to original source...
- Mancia G, et al. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) 2007. Guidelines for the management of arterial hypertension. J Hypertens 2007;25:1105-87.
Go to original source...
Go to PubMed...
- Widimský J. Léčba hypertenze starších osob - renesance diuretik. Remedia 1994;4:109-11.
- Widimský J. Nežádoucí účinky thiazidových diuretik a chlorthalidonu z pohledu 90. let. Remedia 1994;4:259-62.
- Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000;355:865-72.
Go to original source...
- Amery A, Birkenhäger W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985;1:1349-54.
Go to original source...
- Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J 1986;293:1145-52.
Go to original source...
Go to PubMed...
- Dahlöf B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish trial in Old Patients with Hypertension (STOP - Hypertension). Lancet 1991;338:1281-5.
Go to original source...
- MRC Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992;304:405-12.
Go to original source...
- Medical Research Council Working Party: MRC trial of treatment of mild hypertension in older adults: principal results. Br Med J 1985;291:97-104.
Go to original source...
- Kostis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1997;278:212-6.
Go to original source...
- Black HR, Elliott WJ, Grandits G, et al, for the CONVINCE Research Group. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003;289:2073-82.
Go to original source...
Go to PubMed...
- Metoki H, Ohkubo T, Kikuya M, et al. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline. The Ohasama Study. Hypertension 2006;47:149-54.
Go to original source...
Go to PubMed...
- Forette F, Seux M-L, Staessen JA, et al. The prevention of dementia with antihypertensive treatment. New evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002;162:2046-52.
Go to original source...
- Forette F, Seux ML, Thijs L, Staessen JA. Antihypertensive treatment and prevention of dementia in older patients with isolated systolic hypertension: The Syst-Eur results. J Hypertens 1998;16 (Suppl 2):22.
- CIBIS Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II). Lancet 1999;353:9-13.
Go to original source...
- The International Steering Committee. The Metoprolol CR/XL Randomised Intervention Trial in Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
Go to original source...
- Packer M, Coats AJS, Fowler MB, et al, for the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8.
Go to original source...
Go to PubMed...
- Flather MD, Shibata MC, Coats AJ, et al. Randomised trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005;26:215-25.
Go to original source...
Go to PubMed...
- Williams B, Lacy PS, Tom SM, et al, for the CAFE Steering Committee and Writing Committee. The CAFE Investigators, for the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Investigators. Díifferential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Circulation 2006;113:1213-25.
Go to original source...
Go to PubMed...
- Zanchetti A, Grossi G, Lancia G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens 2009;27:923-34.
Go to original source...
Go to PubMed...
- Prospective Studies Collaborators. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
Go to original source...
- PROGRESS Collaborative Group. Randomised trial of perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.
Go to original source...
Go to PubMed...
- Arima H, Chalmers J, Woodward M, et al, for the PROGRESS Collaborative Group. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens 2006;24:1201-8.
Go to original source...
Go to PubMed...
- The Heart Outcomes Prevention Evaluation (HOPE) Investigation. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 2000;342:145-53.
Go to original source...
- The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease; randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003;362:782-8.
- Bosch J, Yusuf S, Pogue J, et al, on behalf of the HOPE Investigators. Use of ramipril in preventing stroke: double blind randomised trial. Br Med J 2002;324:699-702.
Go to original source...
- The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in MICROHOPE substudy. Lancet 2000;355:253-9.
Go to original source...
- Estacio RO, Jeffers BW, Gifford N, et al. Effect of blood pressure control on diabetic microvascular complications in patiens with hypertension and type 2 diabetes. Diabetes Care 2000;23 (Suppl 2):B54-B64.
- ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370:829-40.
Go to original source...
Go to PubMed...
- Sleight P, Redon J, Verdecchia P, et al, on behalf of the ONTARGET investigators. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens 2009;27:1360-9.
Go to original source...
Go to PubMed...
- Julius S, Kjeldsen SE, Weber M, et al, for the VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004;363:2022-31.
Go to original source...
Go to PubMed...
- Jamerson K, Weber RA, Bakris GK, et al, for the ACCOMPLISH Trial Investigators. Benazepril plus Amlodipin or Hydrochlorothiazid for Hypertension in High Risk Patients. N Engl J Med 2008;359:2417-28.
Go to original source...
Go to PubMed...
- Beckett NS, Peters R, Fletcher AE, et al, for the HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-98.
Go to original source...
Go to PubMed...
- Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and possible harm of lowering high blood pressure. Lancet 1987;1:581-4.
Go to original source...
- Farnett L, Mulrow CD, Linn WD, et al. The J-curve phenomenon and the treatment of hypertension. JAMA 1991;265:489-95.
Go to original source...
Go to PubMed...
- Staessen J, Bulpitt C, Clement D, et al. Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the elderly. Br Med J 1989;298:1552-6.
Go to original source...
Go to PubMed...
- Somes GW, Pahore M, Shorr RI, et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1999;159: 2004-9.
Go to original source...
- Franklin SS, Khan SA, Wang ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999;100:354-60.
Go to original source...
- Psaty BM, Furberg CD, Kuller LH, et al. Association between blood pressure level and the risk of myocardial infarction, stroke and total mortality, The Cardiovascular Health Study. Arch Intern Med 2001;161:1183-92.
Go to original source...
- Yusuf S, Pepine CJ, Garces C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992;340:1173-8.
Go to original source...
- Boutitie F, Gueyffier F, Pocock S, et al. J-shaped relationship between blood pressure and mortality in hypertensives patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med 2002;136:438-48.
Go to original source...
- Nissen SE, Tuscu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. The CAMELOT Study: A randomized controlled trial. JAMA 2004;292:2217-26.
Go to original source...
Go to PubMed...
- Spahi I, Tuzcu EM, Schoenhagen P, et al. Effects of normal, pre-hypertensive, and hypertensives blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol 2006;48:833-8.
Go to original source...
Go to PubMed...
- Messerli FH, Mancia G, Conti R, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 2006;144:884-93.
Go to original source...
- Pepine CJ, Handberg EM, Cooper-DeHoff BM, et al, for the INVEST Investigators. A calcium antagonist vs. non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil SR/Trandolapril Study (INVEST): A randomized controlled trial. JAMA 2003;290:2805-16.
Go to original source...
Go to PubMed...
- Messerli FH, Mancia G, Weber MA, et al. Low blood pressure is associated with increased cardiovascular morbidity (J-shaped curve) in treated hypertensive patients with increased cardiovascular risk: The VALUE Randomized Trial. Proceedings from the 58th Annual Scientific Session of the American College of Cardiology, Orlando, March 29-April 1, 2009. J Am Coll Cardiol 2009;53 (Suppl A):A46.
- Fagard RH, Staessen JA, Thijs L, et al. On-treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med 2007;167: 1884-91.
Go to original source...
Go to PubMed...
- Chaudhry SI, Kromholz HM, Foody JM. Systolic hypertension in older persons. JAMA 2004;292:1074-80.
Go to original source...
Go to PubMed...
- Cushman WC, Materson BJ, Williams DW, et al. Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled, trial. Hypertension 2001;38:953-7.
Go to original source...
- Kannel WB, Wilson PWF, Nam B-H, D'Agostino RB. A likely explanation for the J-curve of blood pressure cardiovascular risk. Am J Cardiol 2004; 148:16-26.
Go to original source...
Go to PubMed...
- Kaplan NM, Kaplan's Clinical Hypertension.9th edition. Philadelphia: Lippincott Williams & Wilkins, 2006:518.